Home LiteratureArticle Details
PMID: 21391903 Published · ppublish English Editorial Introductory Journal Article

Pharmaceutical reactivation of p53 pathways in cancer.

Current pharmaceutical design ·Vol. 17 ·No. 6 ·2011-00-00 ·Pages 534-5

Azmi AS

Abstract

暂无摘要

MeSH Terms
Animals Antineoplastic Agents/therapeutic use Genes, p53 Humans Molecular Targeted Therapy Neoplasms/drug therapy,metabolism Proto-Oncogene Proteins c-mdm2/antagonists & inhibitors,genetics,metabolism Tumor Suppressor Protein p53/metabolism
Chemicals
Antineoplastic Agents Tumor Suppressor Protein p53 MDM2 protein, human Proto-Oncogene Proteins c-mdm2
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Azmi Asfar S
Article Info
Journal
Current pharmaceutical design
Abbr.
Curr Pharm Des
ISSN
1873-4286
DOI
10.2174/138161211795222630
Published
2011-00-00
Pages
534-5
Language
English
Region
United Arab Emirates
NLM ID
9602487
Subset
IM
External Links
PubMed source DOI: 10.2174/138161211795222630 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2